Abstract

Alzheimer’s disease is characterized by cognitive dysfunction and aging is an important predisposing factor; however, the pathological and therapeutic mechanisms are not fully understood. Recently, the role of gut microbiota in Alzheimer’s disease has received increasing attention. The cognitive function in senescence-accelerated mouse prone 8 (SAMP8) mice was significantly decreased and the Chao 1 and Shannon indices, principal coordinates analysis, and principal component analysis results were notably abnormal compared with that of those in senescence-accelerated mouse resistant 1 (SAMR1) mice. Moreover, 27 gut bacteria at six phylogenetic levels differed between SAMP8 and SAMR1 mice. In a separate study, we transplanted fecal bacteria from SAMP8 or SAMR1 mice into pseudo germ-free mice. Interestingly, the pseudo germ-free mice had significantly lower cognitive function prior to transplant. Pseudo germ-free mice that received fecal bacteria transplants from SAMR1 mice but not from SAMP8 mice showed improvements in behavior and in α-diversity and β-diversity indices. In total, 14 bacteria at six phylogenetic levels were significantly altered by the gut microbiota transplant. These results suggest that cognitive dysfunction in SAMP8 mice is associated with abnormal composition of the gut microbiota. Thus, improving abnormal gut microbiota may provide an alternative treatment for cognitive dysfunction and Alzheimer’s disease.

Highlights

  • Alzheimer’s disease (AD) is a neurodegenerative disease that occurs in the elderly [1, 2]

  • Α-diversity and β-diversity of the gut microbiota in senescence-accelerated mouse resistant 1 (SAMR1) and senescenceaccelerated mouse prone 8 (SAMP8) mice α-diversity refers to the diversity of bacteria or species within a community or habitat and is mainly concerned with the number of bacteria or species therein [22]

  • We found that SAMP8 mice have deficits in spatial learning and memory, consistent with those described in previous studies [24, 25]

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a neurodegenerative disease that occurs in the elderly [1, 2]. In addition to aging symptoms, senescence-accelerated mouse prone 8 (SAMP8) mice show aging-related learning and memory impairment and cognitive dysfunction and are commonly used as model animals in AD studies [5, 6]. The differential antidepressant effects of R-ketamine and S-ketamine may be attributed to the differential profiles of the gut microbiota [14]. These findings provide a causal link between the gut and brain where the gut microbiota are an important remote mediator of brain function that affects the development and therapeutic outcomes of brain diseases

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call